Chumakov, I., A. Milet, N. Cholet, G. Primas, A. Boucard, Y. Pereira, E. Graudens, J. Mandel, J. Laffaire, J. Foucquier, F. Glibert, V. Bertrand, K.-A. Nave, M. W. Sereda, E. Vial, M. Guedj, R. Hajj, S. Nabirotchkin and D. Cohen: Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy. In: Orphanet Journal of Rare Diseases 9, 1, Seq. No.: 201 (2014).
The Max Planck Society does not take any responsibility for the content of this export.